Science and Enterprise

Category: New products

  • Therapy Shown to Boost Immune System Against Cancer

    18 April 2016. An experimental treatment was shown in lab mice to enhance immune system cells that can help immunotherapy drugs to reduce solid tumor growth. Researchers from Memorial Sloan Kettering Cancer Center in New York and Infinity Pharmaceuticals in Cambridge, Massachusetts presented their findings yesterday (17 April) at the annual meeting of American Association…

  • Implanted Device Delivers Pancreatic Cancer Drugs

    15 April 2016. An engineering and medical research team developed an implanted device that in lab mice delivers chemotherapy directly to cancerous tumors in the pancreas. The device, designed in a biomedical engineering lab at Massachusetts Institute of Technology and Harvard University, is described in an article appearing 31 March 2016 in the journal Biomaterials…

  • Emergency Snakebite Treatment in Development

    14 April 2016. A new treatment for rattlesnake bites, designed as emergency first-aid until reaching a clinic, is being developed at University of Arizona medical school in Tucson. The therapy, still in preclinical stages, is the work of anesthesiology professor Vance Nielsen and toxicologist Leslie Boyer, founder and director of Arizona’s Viper Institute — short…

  • Technique Extends Bioactive Device Coating Lifetime

    14 April 2016. A new process is shown to regenerate therapeutic coatings on implanted medical devices in lab tests and with animals, possibly extending the devices’ lifetimes in patients. The techniques, developed in the lab of Harvard University biomedical engineering professor Elliot Chaikof, are described in the 13 April 2016 issue of the journal Nature…

  • Cell-Free Synthetic Biochemical Process Devised

    13 April 2016. A biochemistry lab at University of California in Los Angeles developed techniques for producing synthetic bio-based chemicals without processing sugars through cells. The discoveries from the lab of biochemistry professor James Bowie is described in the 11 April 2016 issue of the journal Nature Chemical Biology (paid subscription required). Bowie, with postdoctoral…

  • Tropical Disease Diagnostics Now on Market

    12 April 2016. PATH research institute and medical test developer Standard Diagnostics are making available tests for the tropical diseases onchocerciasis and lymphatic filariasis. The rapid, point-of-care tests are designed to help health authorities in Africa and other regions better monitor the spread of the diseases in campaigns to eradicate their occurrence. Onchocerciasis is an…

  • NIH Funds Biosensors to Monitor Oxygen in Tissue

    11 April 2016. Profusa Inc., a company designing sensors that measure tissue oxygen levels in individuals with peripheral artery disease, received an NIH grant to advance its technology. The $225,000 Small Business Innovation Research grant for 2016 is divided between two agencies of National Institutes of Health: National Center for Advancing Translational Sciences and National…

  • Flair4IT Helps Cloud Computing Become Mainstream in the EU

    – Sponsored Content – 11 April 2016. Flair4IT, a UK based IT agency, has been working on making the cloud more mainstream in the EU. They have looked specifically at software applications and infrastructures. To enable the market to become more aware of cloud computing, and to make it as common as what it is…

  • Smartphone-Based Sensor Gives Early Epilepsy Warning

    8 April 2016. An academic and business consortium in Germany is developing a small sensor worn in the ear that detects and warns of seizures in people with epilepsy. The 3-year Epitect project to develop the system, including smartphone software and cloud-based analytics, is led by University Hospital Bonn and supported with €2 million ($US…

  • Start-Up Licensing Biologic Delivery Nanoparticles

    8 April 2016. A start-up enterprise is licensing research from a university pharmacy lab that harnesses nanoscale particles to boost the performance of biologic therapies. Financial details of the agreement between Zoetic Pharmaceuticals in Amherst, New York and University at Buffalo were not disclosed. Biologic therapies are synthetic proteins derived from living systems, such as…